Target intelligence / Profile preview

Neurogenesis and angiogenesis regulatory pathways

Molecular classification
Biological Pathway, Signaling Network
01

Overview

Neurogenesis and angiogenesis regulatory pathways represent the complex, coordinated signaling networks that govern the simultaneous development and repair of the nervous and vascular systems (Louissaint et al., 2002, Neuron). These pathways are linked through shared molecular mediators such as vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), and the Notch and Wnt signaling systems, which facilitate "neurovascular coupling" (Ruiz de Almodovar et al., 2009, Nature Reviews Neuroscience). In the central nervous system, these processes are critical for maintaining the neurogenic niche, where endothelial cells provide essential signals for neural stem cell self-renewal and differentiation (Sun et al., 2003, Journal of Clinical Investigation). Dysregulation of these pathways is implicated in various pathologies, including neurodegenerative diseases like Alzheimer's, ischemic stroke, and certain types of cancer where aberrant angiogenesis supports tumor growth (Zacchigna et al., 2008, Journal of Internal Medicine). While these pathways offer numerous therapeutic opportunities, targeting them is challenging due to the risk of systemic side effects and the need for precise spatial and temporal control of signaling (Carmeliet, 2003, Nature Medicine).

Other names
Neurovascular couplingAngioneurogenesisNeurovascular niche regulation
02

Mechanism of action

Modulation of growth factor signaling (e.g., VEGF, BDNF) and developmental pathways (e.g., Notch, Wnt) to regulate the formation and maintenance of blood vessels and neurons.

03

Biological functions

NeurogenesisAngiogenesisSignal transductionCell proliferationCell differentiation
04

Disease associations

CancerNeurodegenerative diseaseStrokeIschemic diseaseTraumatic brain injury
05

Safety considerations

HypertensionHemorrhageNeurotoxicityImpaired wound healingOncogenic potential
06

Interacting drugs

Bevacizumab

4 more in the full profile.

07

Biomarkers

Vascular endothelial growth factor (VEGF)Brain-derived neurotrophic factor (BDNF)CD31 (PECAM-1)Doublecortin (DCX)Ki-67

Beyond the preview

Go deeper on Neurogenesis and angiogenesis regulatory pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurogenesis and angiogenesis regulatory pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call